Reviews and feature articleAutoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses
Section snippets
The inflammasome as sensor of danger and instigator of autoinflammation
Our immune system has evolved to protect our bodies against microbial infections and cellular waste that accumulate when cells are damaged or die. Two types of immune defense systems have emerged. The recognition of exogenous and endogenous danger by the innate immune system is mediated through pattern-recognition receptors, which we inherit and are not subject to adaptation or fine tuning through gene rearrangement or somatic mutation as we get older. Receptors of the innate immune system bind
IL-1 as a prototypic “alarm” cytokine
IL-1 helps coordinate the immune system's early response to exogenous and endogenous danger, serving as a prototypic alarm cytokine.23 IL-1α and IL-1β were the first members to be described in a now 11-member family of IL-1 molecules that includes at least one IL-1 receptor antagonist (IL-1Ra) molecule.24, 25 The genes for 9 members of this family (all except IL-18 [IL-1F4] and IL-33 [IL-1F11]) are encoded in a cluster on the long arm of chromosome 2. In addition, the type I and II IL-1
Early clinical studies with IL-1Ra in sepsis and rheumatoid arthritis
Based on the observation that IL-1β blockade had attenuated the severity of disease and mortality in experimental models of shock and sepsis,30 clinical trials of the recombinant IL-1Ra anakinra were conducted in the early 1990s to asses its utility in these 2 conditions. The results of a phase II study suggested a possible benefit, with anakinra reducing 28-day all-cause mortality in a dose-dependent manner.31 However, based on a subsequent phase III trial that failed to demonstrate a
Clinical presentation
Historically, CAPS was described not as a single entity but as 3 different disorders that were not recognized as related to one another until their common genetic cause was established. These diseases are familial cold urticaria (now known as FCAS), MWS, and NOMID, which was first named CINCA syndrome. These conditions were initially not recognized as related because of striking differences in severity, multiorgan disease manifestations, and long-term morbidity and mortality, although they do
DIRA
We recently reported a series of 9 patients with a severe autoinflammatory condition with some similarity to NOMID who had homozygous mutations in IL1RN.15 Eight of the 9 patients had inactivating point mutations in IL1RN, whereas the remaining patient, a child from Puerto Rico, harbored a 175-kb genomic deletion that encompassed IL1RN and 5 other genes in the IL1 family (IL1F9, IL1F6, IL1F8, IL1F5, IL1F10, and IL1RN, from centromere to telomere). In an accompanying case report in the New
IL-1 blockade in other autoinflammatory diseases
Anakinra has also been used to prevent attacks and reduce systemic inflammation in patients with colchicine-resistant FMF,50, 51, 52 hyperimmunoglobulinemia D with periodic fever syndrome,53, 54 and TNF receptor–associated periodic syndrome,55, 56, 57 and good responses were also reported in patients with Blau syndrome58 and some with pyogenic arthritis, pyoderma gangrenosum, and acne.59 In addition to the effect in monogenic diseases, a number of presumed polygenic autoinflammatory diseases
Summary
The systemic autoinflammatory diseases are a group of illnesses characterized by episodic or sometimes chronic inflammation without evidence of high-titer autoantibodies or antigen-specific T lymphocytes. Monogenic autoinflammatory diseases are inborn errors of the phylogenetically ancient innate immune system, with its predominance of myeloid cells and germline receptors, whereas monogenic autoimmune diseases affect primarily acquired or adaptive immunity, with its predominance of lymphocytes
References (72)
- et al.
Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes
Cell
(1999) - et al.
Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes
Am J Hum Genet
(2002) - et al.
Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome
Blood
(2005) Plant immunity and film noir: what gumshoe detectives can teach us about plant-pathogen interactions
Cell
(2002)- et al.
NLR, the nucleotide-binding domain leucine-rich repeat containing gene family
Curr Opin Immunol
(2008) - et al.
The inflammasome: a danger sensing complex triggering innate immunity
Curr Opin Immunol
(2007) Biologic basis for interleukin-1 in disease
Blood
(1996)- et al.
Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs
J Biol Chem
(2004) The balance between IL-1 and IL-1Ra in disease
Cytokine Growth Factor Rev
(2002)- et al.
The physiologic basis for anticytokine clinical trials in the treatment of sepsis
J Am Coll Surg
(1998)
Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist
Am J Kidney Dis
Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation
J Pediatr
Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever
J Allergy Clin Immunol
Muckle-Wells syndrome: case report and review of cutaneous pathology
J Am Acad Dermatol
Anakinra: new therapeutic approach in children with familial Mediterranean fever resistant to colchicine
Joint Bone Spine
Beneficial response to interleukin 1 receptor antagonist in traps
Am J Med
IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission
J Allergy Clin Immunol
[Still's disease (systemic-onset juvenile idiopathic arthritis)]
Arch Pediatr
The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever
Cell
The French FMF Consortium. A candidate gene for familial Mediterranean fever
Nat Genet
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group
Nat Genet
Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome
Nat Genet
Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome
Nat Genet
De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases
Arthritis Rheum
Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder
Hum Mol Genet
CARD15 mutations in Blau syndrome
Nat Genet
Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome)
J Med Genet
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism
Nat Genet
Mutations in NALP12 cause hereditary periodic fever syndromes
Proc Natl Acad Sci U S A
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist
N Engl J Med
An autoinflammatory disease due to homozygous deletion of the IL1RN locus
N Engl J Med
A proposed classification of the immunological diseases
PLoS Med
Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (∗)
Annu Rev Immunol
Recognition of microorganisms and activation of the immune response
Nature
Immunological and inflammatory functions of the interleukin-1 family
Annu Rev Immunol
Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)
J Clin Invest
Cited by (0)
(Supported by an educational grant from Merck & Co., Inc.)
Series editors: Joshua A. Boyce, MD, Fred Finkelman, MD, William T. Shearer, MD, PhD, and Donata Vercelli, MD